Repression of SREBP-1c and its targets (ACC, FAS, SCD-1 and GPAT) in the pathway of fatty acid and triglyceride synthesis may indicate an inhibition of de novo lipogenesis in adipose tissue in cancer cachexia. This evidence concerns the gene SCD and cancer.